Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Active Biotech Major Shareholding Notification 2023

Nov 10, 2023

3133_iss_2023-11-10_92eff074-7507-471b-a813-84bab672130e.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Active Biotech AB (publ)

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument Aktier
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Share loan
Date 09/11/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 10,282,663
Directly held voting rights 0
Indirectly held voting rights 10,282,663
Percentage
Directly held shares 3.87813 %
Directly held voting rights 0 %
Indirectly held voting rights 3.87813 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 3.87813 % 10,282,663
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled 1.75606 % 4,656,105
Total 5.63419 % 14,938,768

Group total holdings

Voting rights 14,938,768 Percentage of voting rights 5.63419

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Angivet gränsvärde har underskridits på grund av utlåning av aktier.

Published

10/11/2023 13:12

Contact

Name Joakim Lomell

Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25